Mar 21, 2023 | Brand Name Drugs, Diabetes, Generic Drugs, MedBen Rx, MedBen University, Pharmacy Benefits Manager (PBM), Prescription drugs, Rx Costs, Rx prices, Savings
Earlier this month, drug manufacturer Eli Lilly announced that it cutting the cost of two of its prescription brand insulins, Humalog and Humulin, by 70%, and capping out-of-pocket costs for privately insured patients at $35 a month. Competing...
Mar 6, 2023 | Access solution, Access solutions, MedBen Rx, Medicare, Research, Rx Costs, Rx prices, Rx Spending, Savings, Specialty Drugs
Employers pay up to 30 times as much for specialty drugs than Medicare does, new research finds. According to the JAMA Health Forum, for the 10 most commonly used specialty drugs, employer-sponsored insurance (ESI) plans paid prices up to 3,350%...
Feb 21, 2023 | Comparative Effectiveness, MedBen Rx, Research, Rx Advertising, Rx Costs, Rx prices, Rx Spending, TruDataRx
Drug companies spend $6 billion per year on direct-to-consumer ads with the goal of getting patients to ask their doctors to prescribe drugs that, in many instances, cost substantially more but are less effective than their current medications. And with no comparative...
Feb 3, 2023 | Gene therapy, Inflation, MedBen Rx, Rx Costs, Rx prices, Rx Spending, Savings, Specialty Drugs
Even though health care costs have not seen the same rate of inflation as other industries, that’s about to change. Fortunately, MedBen has a variety of inflation-hedging solutions to counter rising costs. As a recent Self-Insurer article notes, health care costs...
Feb 1, 2023 | Legislation, MedBen Rx, Pharmacy Benefits Manager (PBM), Rx Costs, Rx prices, Rx Spending
Pharmacy benefits managers (PBMs) are increasingly being called to answer for their questionable business practices at multiple levels of government. On the state level, in recent months: A major PBM has settled with Iowa and at least 14 other states for...
Jan 23, 2023 | Avande, Gene therapy, Luke Burchard, MedBen Rx, Rx Costs, Rx prices, Rx Spending, Savings
In two recent articles, we touched on the growing prevalence of high-cost drugs, some with price tags in the thousands and even millions of dollars: Drugmakers are raising prices on over 350 unique drugs this month.Innovative gene therapies have emerged that cost as...
